Goldman Sachs’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.59M | Buy |
2,361,184
+146,237
| +7% | +$408K | ﹤0.01% | 2587 |
|
|
2025
Q1 | $7.95M | Sell |
2,214,947
-75,281
| -3% | -$270K | ﹤0.01% | 2396 |
|
|
2024
Q4 | $7.21M | Buy |
2,290,228
+1,789,947
| +358% | +$5.64M | ﹤0.01% | 2568 |
|
|
2024
Q3 | $1.41M | Sell |
500,281
-216,048
| -30% | -$609K | ﹤0.01% | 3569 |
|
|
2024
Q2 | $881K | Sell |
716,329
-480,502
| -40% | -$591K | ﹤0.01% | 3646 |
|
|
2024
Q1 | $950K | Buy |
1,196,831
+642,873
| +116% | +$510K | ﹤0.01% | 3652 |
|
|
2023
Q4 | $527K | Sell |
553,958
-11,974
| -2% | -$11.4K | ﹤0.01% | 3914 |
|
|
2023
Q3 | $611K | Sell |
565,932
-179,938
| -24% | -$194K | ﹤0.01% | 3798 |
|
|
2023
Q2 | $669K | Sell |
745,870
-229,769
| -24% | -$206K | ﹤0.01% | 3828 |
|
|
2023
Q1 | $825K | Buy |
975,639
+151,931
| +18% | +$128K | ﹤0.01% | 3786 |
|
|
2022
Q4 | $766K | Buy |
823,708
+15,528
| +2% | +$14.4K | ﹤0.01% | 3843 |
|
|
2022
Q3 | $1.37M | Buy |
808,180
+73,643
| +10% | +$125K | ﹤0.01% | 3639 |
|
|
2022
Q2 | $1.57M | Sell |
734,537
-1,464,719
| -67% | -$3.13M | ﹤0.01% | 3629 |
|
|
2022
Q1 | $7.81M | Buy |
2,199,256
+797,158
| +57% | +$2.83M | ﹤0.01% | 2449 |
|
|
2021
Q4 | $5.22M | Buy |
1,402,098
+491,565
| +54% | +$1.83M | ﹤0.01% | 2769 |
|
|
2021
Q3 | $6.73M | Buy |
910,533
+737,828
| +427% | +$5.45M | ﹤0.01% | 2575 |
|
|
2021
Q2 | $2.3M | Sell |
172,705
-149,447
| -46% | -$1.99M | ﹤0.01% | 3401 |
|
|
2021
Q1 | $2.44M | Buy |
322,152
+304,302
| +1,705% | +$2.3M | ﹤0.01% | 3208 |
|
|
2020
Q4 | $299K | Buy |
+17,850
| New | +$299K | ﹤0.01% | 4079 |
|